{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:57:13Z","timestamp":1787061433024,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.radonc.2024.110520","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T03:42:04Z","timestamp":1725507724000},"page":"110520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Analysis of re-recurrent rectal cancer after curative treatment of locally recurrent rectal cancer"],"prefix":"10.1016","volume":"200","author":[{"given":"F.","family":"Piqeur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Coolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nordkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.M.J.","family":"Creemers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.H.N.","family":"Tijssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.G.J.","family":"Neggers-Habraken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.J.T.","family":"Rutten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Nederend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.A.M.","family":"Marijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.W.A.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.M.U.","family":"Peulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110520_b0005","doi-asserted-by":"crossref","unstructured":"Fadel MG, Ahmed M, Malietzis G, et al. Oncological outcomes of multimodality treatment for patients undergoing surgery for locally recurrent rectal cancer: A systematic review. Cancer Treat Rev. 2022;109. doi:10.1016\/j.ctrv.2022.102419.","DOI":"10.1016\/j.ctrv.2022.102419"},{"key":"10.1016\/j.radonc.2024.110520_b0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/DCR.0000000000000547","article-title":"Treatment of locally recurrent rectal carcinoma in previously (Chemo)irradiated patients: a review","volume":"59","author":"Van Der Meij","year":"2016","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.radonc.2024.110520_b0015","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1503\/cjs.025911","article-title":"Intentionally curative treatment of locally recurrent rectal cancer: A systematic review","volume":"56","author":"Tanis","year":"2013","journal-title":"Can J Surg"},{"key":"10.1016\/j.radonc.2024.110520_b0020","doi-asserted-by":"crossref","unstructured":"Hagemans JAW, van Rees JM, Alberda WJ, et al. Locally recurrent rectal cancer; long-term outcome of curative surgical and non-surgical treatment of 447 consecutive patients in a tertiary referral centre. Eur J Surg Oncol. 2020;46(3). doi:10.1016\/j.ejso.2019.10.037.","DOI":"10.1016\/j.ejso.2019.10.037"},{"key":"10.1016\/j.radonc.2024.110520_b0025","doi-asserted-by":"crossref","unstructured":"Detering R, Karthaus EG, Borstlap WAA, et al. Treatment and survival of locally recurrent rectal cancer: A cross-sectional population study 15 years after the Dutch TME trial. Eur J Surg Oncol. 2019;45(11). doi:10.1016\/j.ejso.2019.06.016.","DOI":"10.1016\/j.ejso.2019.11.032"},{"key":"10.1016\/j.radonc.2024.110520_b0030","doi-asserted-by":"crossref","unstructured":"Nordkamp S, Voogt ELK, van Zoggel DMGI, et al. Locally recurrent rectal cancer: oncological outcomes with different treatment strategies in two tertiary referral units. Br J Surg. 2022;109(7). doi:10.1093\/bjs\/znac083.","DOI":"10.1093\/bjs\/znac083"},{"key":"10.1016\/j.radonc.2024.110520_b0035","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/bjs\/znad094","article-title":"Locally recurrent rectal cancer: Oncological outcomes for patients with a pathological complete response after neoadjuvant therapy","volume":"110","author":"Nordkamp","year":"2023","journal-title":"Br J Surg"},{"key":"10.1016\/j.radonc.2024.110520_b0040","doi-asserted-by":"crossref","unstructured":"Glynne-Jones R, Wyrwicz L, Tiret E, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals Oncol. 2017;2doi:10.1093\/annonc\/mdx224.","DOI":"10.1093\/annonc\/mdx224"},{"key":"10.1016\/j.radonc.2024.110520_b0045","doi-asserted-by":"crossref","unstructured":"Beyond TME Collaborative. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. In: The British Journal of Surgery. Vol 100. ; 2013. doi:10.1002\/bjs.9192.","DOI":"10.1002\/bjs.9192"},{"key":"10.1016\/j.radonc.2024.110520_b0050","doi-asserted-by":"crossref","unstructured":"Collaborative P. Contemporary Management of Locally Advanced and Recurrent Rectal Cancer: Views from the PelvEx Collaborative. Cancers (Basel). 2022;14(5). doi:10.3390\/cancers14051161.","DOI":"10.3390\/cancers14051161"},{"key":"10.1016\/j.radonc.2024.110520_b0055","doi-asserted-by":"crossref","unstructured":"Voogt E, Burger P. Induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as neoadjuvant treatment for locally recurrent rectal cancer: the PelvEx II study. Eur J Surg Oncol. 2021;47(2). doi:10.1016\/j.ejso.2020.11.204.","DOI":"10.1016\/j.ejso.2020.11.204"},{"key":"10.1016\/j.radonc.2024.110520_b0060","doi-asserted-by":"crossref","unstructured":"Piqeur F, Hupkens B, Nordkamp S, et al. PD-0887 Quality assurance of delineation for locally recurrent rectal cancer: PelvEx II data (NCT04389086). Radiother Oncol. 2023;182. doi:10.1016\/s0167-8140(23)09012-6.","DOI":"10.1016\/S0167-8140(23)09012-6"},{"key":"10.1016\/j.radonc.2024.110520_b0065","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1245\/s10434-023-13141-y","article-title":"Locally recurrent rectal cancer: toward a second chance at cure? A population-based, retrospective Cohort study","volume":"30","author":"Swartjes","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.radonc.2024.110520_b0070","doi-asserted-by":"crossref","unstructured":"Piqeur F, Creemers DMJ, Banken E, et al. Dutch national guidelines for locally recurrent rectal cancer. Cancer Treat Rev. Published online April 2024:102736. doi:10.1016\/j.ctrv.2024.102736.","DOI":"10.1016\/j.ctrv.2024.102736"},{"key":"10.1016\/j.radonc.2024.110520_b0075","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.radonc.2022.11.008","article-title":"Development of a consensus-based delineation guideline for locally recurrent rectal cancer","volume":"177","author":"Piqeur","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110520_b0080","doi-asserted-by":"crossref","unstructured":"Nijkamp J, Kusters M, Beets-Tan RGH, et al. Three-dimensional analysis of recurrence patterns in rectal cancer: The cranial border in hypofractionated preoperative radiotherapy can be lowered. Int J Radiat Oncol Biol Phys. 2011;80(1). doi:10.1016\/j.ijrobp.2010.01.046.","DOI":"10.1016\/j.ijrobp.2010.01.046"},{"key":"10.1016\/j.radonc.2024.110520_b0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.radonc.2016.07.017","article-title":"International consensus guidelines on Clinical Target Volume delineation in rectal cancer","volume":"120","author":"Valentini","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110520_b0090","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.clon.2017.11.009","article-title":"External Beam Re-irradiation in Rectal Cancer","volume":"30","author":"Owens","year":"2018","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110520_b0095","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11888-017-0360-y","article-title":"Pelvic Reirradiation for the Treatment of Locally Recurrent Rectal Cancer","volume":"13","author":"Tao","year":"2017","journal-title":"Curr Colorectal Cancer Rep"},{"key":"10.1016\/j.radonc.2024.110520_b0100","doi-asserted-by":"crossref","unstructured":"Wang J, Prabhakaran S, Larach T, et al. Treatment strategies for locally recurrent rectal cancer. Eur J Surg Oncol. 2022;48(11). doi:10.1016\/j.ejso.2022.05.011.","DOI":"10.1016\/j.ejso.2022.05.011"},{"issue":"JUN","key":"10.1016\/j.radonc.2024.110520_b0105","article-title":"Treatment outcomes of reirradiation in locoregionally recurrent rectal cancer and clinical significance of proper patient selection","volume":"9","author":"Chung","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2024.110520_b0110","doi-asserted-by":"crossref","first-page":"370","DOI":"10.5114\/jcb.2022.118305","article-title":"Narrowing the difference in dose delivery for IOERT and IOBT for locally advanced and locally recurrent rectal cancer","volume":"14","author":"Verrijssen","year":"2022","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.radonc.2024.110520_b0115","doi-asserted-by":"crossref","unstructured":"Voogt ELK, van Rees JM, Hagemans JAW, et al. Intraoperative electron beam radiation therapy (IOERT) versus high-dose-rate intraoperative brachytherapy (HDR-IORT) in patients with an R1 resection for locally advanced or locally recurrent rectal cancer. Int J Radiat Oncol Biol Phys. 2021;110(4). doi:10.1016\/j.ijrobp.2021.02.006.","DOI":"10.1016\/j.ijrobp.2021.02.006"},{"issue":"1","key":"10.1016\/j.radonc.2024.110520_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity."},{"issue":"1","key":"10.1016\/j.radonc.2024.110520_b0125","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.radonc.2024.110520_b0130","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.surg.2020.04.063","article-title":"Meta-analysis of survival and functional outcomes after total mesorectal excision with or without lateral pelvic lymph node dissection in rectal cancer surgery","volume":"168","author":"Hajibandeh","year":"2020","journal-title":"Surgery"},{"key":"10.1016\/j.radonc.2024.110520_b0135","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1245\/s10434-021-10070-6","article-title":"Re-irradiation in patients with recurrent rectal cancer is safe and feasible","volume":"28","author":"Dijkstra","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.radonc.2024.110520_b0140","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.radonc.2014.11.021","article-title":"Reirradiation of locally recurrent rectal cancer: A systematic review","volume":"113","author":"Guren","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110520_b0145","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.radonc.2019.05.021","article-title":"Practical effectiveness of re-irradiation with or without surgery for locoregional recurrence of rectal cancer: A meta-analysis and systematic review","volume":"140","author":"Lee","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110520_b0150","article-title":"Locally recurrent rectal cancer: oncological outcomes of neoadjuvant chemoradiotherapy with or without induction chemotherapy","author":"Nordkamp","year":"2023","journal-title":"Brit J Surg."},{"key":"10.1016\/j.radonc.2024.110520_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.03.005","article-title":"Locally recurrent rectal cancer and distant metastases: is there still a chance ofcure?","author":"van Rees","year":"2023","journal-title":"Eur J Surg Oncol."}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024034984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024034984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T12:25:49Z","timestamp":1750681549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814024034984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":31,"alternative-id":["S0167814024034984"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110520","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of re-recurrent rectal cancer after curative treatment of locally recurrent rectal cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110520","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110520"}}